Clinical trials: Gout Attack
Gout Attack
Pilot Study Evaluating The Efficacy Of Etanercept In Acute Gout
The purpose of this pilot study is to investigate the safety and efficacy of etanercept (Enbrel™; Amgen) for the treatment of an acute gout attack will be non-inferior to triamcinolone acetonide an FDA approved drug to treat…
- Trial name
- NCT03636373
- Testing
- Etanercept, Triamcinolone Acetonide
- Where
- United States
- Volunteers
- 5 people
- Sponsor
- Rutgers, The State University of New Jersey
Gout Attack
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Evaluation of RPH-104 Administered at Different Doses to Patients With Acute Gout Attack
The primary goal of the study was to evaluate the parameters of efficacy, pharmacokinetics, pharmacodynamics, safety and tolerability of a single dose of RPH-104 in adult patients with acute gout attack.
- Trial name
- NCT04067492
- Testing
- RPH - 104, Voltaren®
- Where
- 11 sites in Russia
- Volunteers
- 47 people
- Sponsor
- R-Pharm